The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated...
Main Authors: | Amani Thomas Mori, Eliangiringa Amos Kaale, Frida Ngalesoni, Ole Frithjof Norheim, Bjarne Robberstad |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI |
Similar Items
-
Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
by: Mori Amani, et al.
Published: (2012-09-01) -
Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.
by: Frida Ngalesoni, et al.
Published: (2017-01-01) -
Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
by: Mori Amani, et al.
Published: (2012-03-01) -
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country – the case of Tanzania
by: Hemed Yusuf, et al.
Published: (2007-02-01) -
The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania.
by: Eliangiringa Kaale, et al.
Published: (2016-01-01)